State of Pharmaceutical Marketing in 2026
Pharmaceutical marketing in 2025 has shifted from traditional outreach to AI‑driven, data‑centric strategies. Competitive intelligence now relies on machine learning, natural‑language processing and real‑world evidence to anticipate pipeline moves and regulatory shifts. The FDA’s recent REMS relaxations for CAR‑T and clozapine reduce market barriers, while U.S. firms sealed fourteen China biotech licensing deals worth $18.3 billion, underscoring a global sourcing pivot. Omnichannel engagement is embedded in electronic health records, delivering personalized, real‑time messaging to clinicians and patients.
GUEST COMMENTARY – The Zero-Click Wake-Up Call
Pharma marketers are confronting a zero‑click era as GenAI tools like ChatGPT and OpenEvidence answer health queries without directing users to brand sites. A Datos study shows 56% of desktop and up to 77% of mobile Google searches now end...
HealthcareWATCH
Diaceutics reports that 65% of eligible advanced non‑small cell lung‑cancer patients in the U.S. still miss optimal targeted therapies, with patient loss now concentrated at the treatment‑decision stage. Innovent Biologics unveiled a suite of oral GLP‑1 and amylin candidates aimed...
Marcus Evans Announces the Healthcare CEO & Executive Strategy Summit, 19 – 20 October 2026, Las Vegas, Nevada
Marcus Evans will host the invitation‑only Healthcare CEO & Executive Strategy Summit on October 19‑20, 2026, at the Red Rock Casino Resort and Spa in Las Vegas. The two‑day event brings together senior hospital and health‑system leaders with select suppliers...
Accenture Song Will Buy Whalar, Gaining Global Scale in Influencer Marketing
Accenture Song announced it will acquire influencer‑marketing agency Wharl, expanding its footprint in the creator economy. The terms were not disclosed, but the deal is touted as the sector’s largest transaction, eclipsing Publicis Groupe’s $500 million purchase of Influential. Wharl’s co‑CEOs...
Healthcare CMO Summit 2026: A Focused Forum for America’s Senior Clinical Leaders
The Healthcare CMO Summit 2026 will convene on September 17‑18 at Encore Boston Harbor, gathering senior clinical leaders from across the United States. Organized by Marcus Evans, the invitation‑only two‑day event aims to accelerate resilient health systems through peer‑driven dialogue,...
Causaly and Microsoft Collaborate to Connect Scientific Computation to Scientific Decision-Making for Life Sciences R&D
Causaly announced a collaboration with Microsoft to integrate Microsoft Discovery’s enterprise‑scale analytics with Causaly’s knowledge‑graph reasoning, creating a single, governed workflow for life‑science R&D. The combined solution moves biopharma teams from raw computational signals to cited, defensible decisions across target...
Virtual Care in America: The Populus Report
The Populus Report defines virtual care as any digital environment where patients and providers exchange clinical attention, positioning telehealth as a subset. Survey data from over 1,250 patients, providers, and pharma marketers shows virtual care accelerates access, with 76% of...
WLH Consulting and Learning Solutions Joins Forces with Prominence Advisors and Tegra Analytics to Deliver End-to-End Commercial Excellence for Life...
WLH Consulting and Learning Solutions has partnered with Prominence Advisors and Tegra Analytics to create an end‑to‑end commercial‑excellence platform for life‑sciences firms. Prominence will supply a governed, AI‑enabled data and cloud foundation, Tegra will convert that data into commercial intelligence...
Focus on Biosimilar Adoption: Driving Uptake Through Strategy
Teva’s U.S. Value & Access team has moved beyond simple payer formulary placement, adopting a holistic ecosystem approach that coordinates payers, providers, pharmacies, and health systems to accelerate biosimilar uptake. By redesigning contracts to include step‑therapy, lower patient cost‑sharing, and...
Gifthealth Delivers Off-The-Shelf Solution to Deliver MFN Pricing
Gifthealth, the nation’s largest direct‑to‑patient (DTP) partner, announced an off‑the‑shelf solution that enables manufacturers to offer most‑favored‑nation (MFN) pricing within as little as 21 days. The platform, which already handles more than 90% of U.S. DTP volume, supports high‑volume drugs...
From Gimmick to Gold Standard
Clinical wearables have transitioned from wellness gadgets to FDA‑recognized trial endpoints, with more than 1,000 interventional studies between 2001 and 2025 already incorporating sensor data. Advances in sensor fidelity, AI‑driven analytics, and regulatory acceptance are enabling continuous cardiac, metabolic, and...
HealthcareWATCH
ICON and Advarra have formed a strategic partnership to create a connected, research‑ready site network that integrates ICON’s global trial services with Advarra’s CTMS, eISF and eSource platforms, promising faster study start‑up and reduced administrative burden. Eli Lilly reported that its...
ElITE 2026 – CHANGE MANAGEMENT CHAMPION – Amy Atwood
Amy Atwood, head of transformation and change management at Real Chemistry’s RC Resolve, brings three decades of experience guiding complex organizational change in healthcare and other sectors. Her people‑first methodology blends strategic discipline with behavioral insight, ensuring transformation initiatives are...
Reimagining Annual Brand Planning with AI
EVERSANA’s fourth annual brand‑planning survey reveals that 60% of pharma marketers lack a trusted single source of truth for brand data, and only half maintain a consistent planning process across the enterprise. Nearly two‑thirds of leaders are already using or...